{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:43:56Z","timestamp":1792727036041,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jcv.2009.01.009","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T16:57:10Z","timestamp":1235494630000},"page":"287-291","source":"Crossref","is-referenced-by-count":15,"title":["Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine"],"prefix":"10.1016","volume":"44","author":[{"given":"Yan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya L.","family":"Cyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2009.01.009_bib1","first-page":"1","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vacine in a pediatric population","volume":"1","author":"Chin","year":"1969","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2009.01.009_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcv.2009.01.009_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiological study of altered clinical reactivity for respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcv.2009.01.009_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcv.2009.01.009_bib5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JVI.57.3.721-728.1986","article-title":"Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus","volume":"57","author":"Prince","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib6","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+T cells","volume":"66","author":"Connors","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0966-842X(94)90662-9","article-title":"Vaccines and cytokine-mediated pathology in RSV infection","volume":"2","author":"Doherty","year":"1994","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jcv.2009.01.009_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1431","article-title":"Respiratory syncytial virus immunobiology and pathogenesis","volume":"297","author":"Graham","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2009.01.009_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/intimm\/4.4.493","article-title":"Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G","volume":"4","author":"Openshaw","year":"1992","journal-title":"Int Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib10","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JVI.70.5.2852-2860.1996","article-title":"Respiratory syncytial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern","volume":"70","author":"Waris","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib11","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib12","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.165.11.6487","article-title":"The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses","volume":"165","author":"Varga","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib13","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1128\/JVI.74.13.6227-6229.2000","article-title":"Respiratory syncytial virus G and\/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB\/c mouse","volume":"74","author":"Tripp","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib14","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.187.11.1921","article-title":"Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia","volume":"187","author":"Sparer","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcv.2009.01.009_bib15","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.188.10.1967","article-title":"Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus","volume":"188","author":"Tebbey","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcv.2009.01.009_bib16","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/JVI.72.4.2871-2880.1998","article-title":"Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge","volume":"72","author":"Johnson","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2249.1998.00650.x","article-title":"The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses","volume":"113","author":"Hu","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib18","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.4049\/jimmunol.169.6.3208","article-title":"Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus","volume":"169","author":"Chen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.femsim.2004.08.010","article-title":"The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703","volume":"43","author":"Hu","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jcv.2009.01.009_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0264-410X(95)98263-A","article-title":"Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb\/c mice that are similar to those generated by experimental infection","volume":"13","author":"Hancock","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib21","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1128\/JVI.70.11.7783-7791.1996","article-title":"Generation of atypical pulmonary inflammatory responses in BALB\/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus","volume":"70","author":"Hancock","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0264-410X(99)00373-4","article-title":"Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge","volume":"18","author":"Mader","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib23","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0264-410X(01)00487-X","article-title":"Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans","volume":"20","author":"Huang","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI117546","article-title":"Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus","volume":"94","author":"Tang","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcv.2009.01.009_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/infdis\/172.3.734","article-title":"Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity","volume":"172","author":"Tang","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2009.01.009_bib26","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1128\/JVI.73.8.6590-6597.1999","article-title":"Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent","volume":"73","author":"Srikiatkhachorn","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib27","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/JVI.79.7.4527-4532.2005","article-title":"Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus","volume":"79","author":"Huang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35105075","article-title":"Strategies for designing and optimizing new generation vaccines","volume":"1","author":"Berzofsky","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/viro.1997.8465","article-title":"Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment","volume":"230","author":"Power","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2009.01.009_bib30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1086\/314778","article-title":"Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies","volume":"179","author":"Siegrist","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2009.01.009_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/viro.2000.0186","article-title":"Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate","volume":"269","author":"Li","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2009.01.009_bib32","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1016\/S0264-410X(02)00217-7","article-title":"Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness","volume":"20","author":"Miller","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib33","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/S0264-410X(03)00119-1","article-title":"CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB\/c mice","volume":"21","author":"Harcourt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib34","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.83.6.1906","article-title":"Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein","volume":"83","author":"Elango","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcv.2009.01.009_bib35","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/JVI.61.10.3163-3166.1987","article-title":"Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity","volume":"61","author":"Johnson","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib36","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.137.12.3973","article-title":"Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants","volume":"137","author":"Bangham","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib37","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1128\/JVI.78.11.6043-6047.2004","article-title":"Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV","volume":"78","author":"Takimoto","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1099\/0022-1317-74-3-453","article-title":"Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium","volume":"74","author":"Martin-Gallardo","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/vim.2000.13.503","article-title":"QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus","volume":"13","author":"Hancock","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/vim.2000.13.57","article-title":"The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12","volume":"13","author":"Hancock","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib41","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1016\/S0264-410X(03)00482-1","article-title":"Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus","volume":"21","author":"Hancock","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib42","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.vaccine.2004.03.035","article-title":"Protollin: a novel adjuvant for intranasal vaccines","volume":"22","author":"Jones","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib43","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","article-title":"Intranasal Protollin\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection","volume":"24","author":"Jones","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib44","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.vaccine.2004.09.010","article-title":"A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice","volume":"23","author":"Chabot","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2249.2006.03097.x","article-title":"Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis","volume":"144","author":"Knight","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib46","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.vaccine.2007.01.037","article-title":"C57Bl\/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine","volume":"25","author":"Cyr","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib47","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(03)00044-6","article-title":"A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV)","volume":"21","author":"Huang","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2009.01.009_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jcv.2009.01.009_bib49","first-page":"137","article-title":"Genetic control of eosinophilia. Analysis of production and response to eosinophil-differentiating factor in strains of mice infected with Trichinella spiralis","volume":"77","author":"Lammas","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib50","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.4049\/jimmunol.170.4.2037","article-title":"IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge","volume":"170","author":"Johnson","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jcv.2009.01.009_bib51","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.77.18.9831-9844.2003","article-title":"Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C\u2013CX3CR1 interaction and expression of substance P","volume":"77","author":"Haynes","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib52","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.78.11.6024-6032.2004","article-title":"Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV","volume":"78","author":"Johnson","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2009.01.009_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcv.2009.01.009_bib54","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1016\/j.vaccine.2007.08.062","article-title":"Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease","volume":"25","author":"Benoit","year":"2007","journal-title":"Vaccine"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653209000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653209000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T04:21:12Z","timestamp":1684902072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653209000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1386653209000432"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2009.01.009","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}